MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells

Hiroaki Nagano, Yoshito Tomimaru, Hidetoshi Eguchi, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, Shogo Kobayashi, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Although we studied previously the mechanisms of resistance of pancreatic cancer cells to gemcitabine (GEM), prediction of the response to GEM remains unsatisfactory. The aim of this study was to investigate the relationship between miR-29a expression and the response to GEM in pancreatic cancer cells. Changes in the growth-inhibitory effect of pancreatic cancer cells (MIAPaCa-2, PSN-1, BxPC-3 and Panc-1) to GEM were examined after overexpression or suppression of miR-29a. We also examined the effect of miR-29a on the Wnt/β-catenin signaling pathway and investigated whether the altered growth-inhibitory effect by miR-29a suppression was weakened after the addition of Wnt3a, a Wnt/β-catenin signaling activator. MIAPaCa-2 and PSN-1 cells transfected with anti-miR-29a showed significantly lower resistance to GEM. In the anti-miR-29a-transfected cells, GEM induced significantly larger numbers of apoptotic cells and S phase accumulation compared to control cells, demonstrated by Annexin V assay and flow cytometric analysis of the cell cycle, respectively. The transfected cells showed overexpression of putative target molecules including Dkk1, Kremen2 and sFRP2 and lower activation of the Wnt/β-catenin signaling pathway. The addition of Wnt3a weakened the augmented growth-inhibitory effect of anti-miR-29a transfection. Our findings suggest that miR-29a expression correlates significantly with the growth-inhibitory effect of GEM and that activation of the Wnt/β-catenin signaling pathway mediated the miR-29a-induced resistance to GEM in pancreatic cancer cell lines.

Original languageEnglish
Pages (from-to)1066-1072
Number of pages7
JournalInternational journal of oncology
Volume43
Issue number4
DOIs
Publication statusPublished - Oct 1 2013

Fingerprint

gemcitabine
Catenins
Wnt Signaling Pathway
MicroRNAs
Pancreatic Neoplasms
Growth
Annexin A5
S Phase
Transfection
Cell Cycle

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells. / Nagano, Hiroaki; Tomimaru, Yoshito; Eguchi, Hidetoshi; Hama, Naoki; Wada, Hiroshi; Kawamoto, Koichi; Kobayashi, Shogo; Mori, Masaki; Doki, Yuichiro.

In: International journal of oncology, Vol. 43, No. 4, 01.10.2013, p. 1066-1072.

Research output: Contribution to journalArticle

Nagano, H, Tomimaru, Y, Eguchi, H, Hama, N, Wada, H, Kawamoto, K, Kobayashi, S, Mori, M & Doki, Y 2013, 'MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells', International journal of oncology, vol. 43, no. 4, pp. 1066-1072. https://doi.org/10.3892/ijo.2013.2037
Nagano, Hiroaki ; Tomimaru, Yoshito ; Eguchi, Hidetoshi ; Hama, Naoki ; Wada, Hiroshi ; Kawamoto, Koichi ; Kobayashi, Shogo ; Mori, Masaki ; Doki, Yuichiro. / MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells. In: International journal of oncology. 2013 ; Vol. 43, No. 4. pp. 1066-1072.
@article{ace8829558dc4fe2b70bec8de3fa48cf,
title = "MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells",
abstract = "Although we studied previously the mechanisms of resistance of pancreatic cancer cells to gemcitabine (GEM), prediction of the response to GEM remains unsatisfactory. The aim of this study was to investigate the relationship between miR-29a expression and the response to GEM in pancreatic cancer cells. Changes in the growth-inhibitory effect of pancreatic cancer cells (MIAPaCa-2, PSN-1, BxPC-3 and Panc-1) to GEM were examined after overexpression or suppression of miR-29a. We also examined the effect of miR-29a on the Wnt/β-catenin signaling pathway and investigated whether the altered growth-inhibitory effect by miR-29a suppression was weakened after the addition of Wnt3a, a Wnt/β-catenin signaling activator. MIAPaCa-2 and PSN-1 cells transfected with anti-miR-29a showed significantly lower resistance to GEM. In the anti-miR-29a-transfected cells, GEM induced significantly larger numbers of apoptotic cells and S phase accumulation compared to control cells, demonstrated by Annexin V assay and flow cytometric analysis of the cell cycle, respectively. The transfected cells showed overexpression of putative target molecules including Dkk1, Kremen2 and sFRP2 and lower activation of the Wnt/β-catenin signaling pathway. The addition of Wnt3a weakened the augmented growth-inhibitory effect of anti-miR-29a transfection. Our findings suggest that miR-29a expression correlates significantly with the growth-inhibitory effect of GEM and that activation of the Wnt/β-catenin signaling pathway mediated the miR-29a-induced resistance to GEM in pancreatic cancer cell lines.",
author = "Hiroaki Nagano and Yoshito Tomimaru and Hidetoshi Eguchi and Naoki Hama and Hiroshi Wada and Koichi Kawamoto and Shogo Kobayashi and Masaki Mori and Yuichiro Doki",
year = "2013",
month = "10",
day = "1",
doi = "10.3892/ijo.2013.2037",
language = "English",
volume = "43",
pages = "1066--1072",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells

AU - Nagano, Hiroaki

AU - Tomimaru, Yoshito

AU - Eguchi, Hidetoshi

AU - Hama, Naoki

AU - Wada, Hiroshi

AU - Kawamoto, Koichi

AU - Kobayashi, Shogo

AU - Mori, Masaki

AU - Doki, Yuichiro

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Although we studied previously the mechanisms of resistance of pancreatic cancer cells to gemcitabine (GEM), prediction of the response to GEM remains unsatisfactory. The aim of this study was to investigate the relationship between miR-29a expression and the response to GEM in pancreatic cancer cells. Changes in the growth-inhibitory effect of pancreatic cancer cells (MIAPaCa-2, PSN-1, BxPC-3 and Panc-1) to GEM were examined after overexpression or suppression of miR-29a. We also examined the effect of miR-29a on the Wnt/β-catenin signaling pathway and investigated whether the altered growth-inhibitory effect by miR-29a suppression was weakened after the addition of Wnt3a, a Wnt/β-catenin signaling activator. MIAPaCa-2 and PSN-1 cells transfected with anti-miR-29a showed significantly lower resistance to GEM. In the anti-miR-29a-transfected cells, GEM induced significantly larger numbers of apoptotic cells and S phase accumulation compared to control cells, demonstrated by Annexin V assay and flow cytometric analysis of the cell cycle, respectively. The transfected cells showed overexpression of putative target molecules including Dkk1, Kremen2 and sFRP2 and lower activation of the Wnt/β-catenin signaling pathway. The addition of Wnt3a weakened the augmented growth-inhibitory effect of anti-miR-29a transfection. Our findings suggest that miR-29a expression correlates significantly with the growth-inhibitory effect of GEM and that activation of the Wnt/β-catenin signaling pathway mediated the miR-29a-induced resistance to GEM in pancreatic cancer cell lines.

AB - Although we studied previously the mechanisms of resistance of pancreatic cancer cells to gemcitabine (GEM), prediction of the response to GEM remains unsatisfactory. The aim of this study was to investigate the relationship between miR-29a expression and the response to GEM in pancreatic cancer cells. Changes in the growth-inhibitory effect of pancreatic cancer cells (MIAPaCa-2, PSN-1, BxPC-3 and Panc-1) to GEM were examined after overexpression or suppression of miR-29a. We also examined the effect of miR-29a on the Wnt/β-catenin signaling pathway and investigated whether the altered growth-inhibitory effect by miR-29a suppression was weakened after the addition of Wnt3a, a Wnt/β-catenin signaling activator. MIAPaCa-2 and PSN-1 cells transfected with anti-miR-29a showed significantly lower resistance to GEM. In the anti-miR-29a-transfected cells, GEM induced significantly larger numbers of apoptotic cells and S phase accumulation compared to control cells, demonstrated by Annexin V assay and flow cytometric analysis of the cell cycle, respectively. The transfected cells showed overexpression of putative target molecules including Dkk1, Kremen2 and sFRP2 and lower activation of the Wnt/β-catenin signaling pathway. The addition of Wnt3a weakened the augmented growth-inhibitory effect of anti-miR-29a transfection. Our findings suggest that miR-29a expression correlates significantly with the growth-inhibitory effect of GEM and that activation of the Wnt/β-catenin signaling pathway mediated the miR-29a-induced resistance to GEM in pancreatic cancer cell lines.

UR - http://www.scopus.com/inward/record.url?scp=84882335174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882335174&partnerID=8YFLogxK

U2 - 10.3892/ijo.2013.2037

DO - 10.3892/ijo.2013.2037

M3 - Article

C2 - 23900458

AN - SCOPUS:84882335174

VL - 43

SP - 1066

EP - 1072

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 4

ER -